Nasdaq

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections

ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...
The New England Journal of Medicine

Treatment of Bacterial Endocarditis with Cephalosporin Derivatives in Penicillin-Allergic Patients — Report of Four Cases

Results of preliminary studies suggest that certain cephalosporin C derivatives may be useful in the treatment of bacterial endocarditis. 11–15 Both cephalothin and cephaloridine have the essential ...
Monthly Prescribing Reference

IV Antibiotic Ceftobiprole Under Review for Serious Bacterial Infections

Credit: Getty Images. Ceftobiprole is a broad spectrum cephalosporin antibiotic. The Food and Drug Administration (FDA) has accepted the New Drug Application for ceftobiprole, an investigational, ...
Drug Store News

Sandoz to acquire GSK's antibiotics cephalosporin business

Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business. The company said the move is aimed at reinforcing its leading global position in antibiotics.
Monthly Prescribing Reference

Removal of EHR Warning Linked to Increase in Cephalosporin Use in Patients With Penicillin Allergy

After removal of the warning, cephalosporin use increased from 17.9% to 27.0% at the intervention site. Removal of the default warning in the electronic health record (EHR) urging the avoidance of ...
FiercePharma

GlaxoSmithKline looks to sell some antibiotics in renewed portfolio shakeup: report

Back in 2017, GlaxoSmithKline initiated a strategic review of its cephalosporins antibiotics business shortly after Emma Walmsley took over as CEO. Though the British drugmaker didn’t go through with ...